Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-14

Clinical Trial Update: Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 clinical trial evaluating the efficacy of lurasidone on cognitive functioning in patients with bipolar disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • lurasidone (lurasidone)

Snippet

Sponsor: Lakshmi N Yatham | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED